{
    "nctId": "NCT03062878",
    "briefTitle": "The Effects of Anthracycline-based Chemotherapy on Peripheral Vascular Function",
    "officialTitle": "The Effects of Anthracycline-based Chemotherapy on Spontaneous Baroreflex Sensitivity, Carotid Artery Stiffness, and Endothelial-dependent Vascular Function.",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Lymphoma, Chemotherapy Effect",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "Spontaneous baroreflex sensitivity",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Give voluntary consent to participate in the study\n* (Group 1) Diagnosed Stage I-III breast cancer or lymphoma cancer with a \\> 2 year life expectancy\n* (Group 1) Current chemotherapy treatment includes anthracyclines\n* (Group 2) History of Stage I-III breast cancer or lymphoma cancer with a \\> 2 year life expectancy\n* (Group 2) 1 - 5 years removed from last date of anthracycline-based chemotherapy\n\nExclusion Criteria:\n\n* History of clinical cardiovascular disease (Atherosclerotic cardiovascular disease (ASCVD) defined by history of acute coronary syndromes, myocardial infarction (MI), stable or unstable angina, coronary or other arterial revascularization, stroke, transient ischemia attack (TIA), or peripheral arterial disease presumed to be of atherosclerotic origin)\n* Not met the above criteria\n* Unable to provide informed consent",
    "sex": "ALL",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}